Literature DB >> 26493818

Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort.

Carole Desthieux1, Anna Molto2, Benjamin Granger3, Alain Saraux4, Bruno Fautrel1, Laure Gossec1.   

Abstract

OBJECTIVE: To assess patient-physician discordance in global assessment of disease activity in early axial spondyloarthritis (axSpA) over time and determinants of discordance.
METHODS: DESIR (Devenir des Spondyloarthropathies Indifférenciées Récentes) is a French, multicentre, longitudinal cohort of patients with early inflammatory back pain suggestive of axSpA. Patient global assessment (PGA) and physician global assessment (PhGA) were rated with a 0-10 numerical rating scale, every 6 months during 2 years then at 3 years. Discordance was defined by the absolute difference |PGA-PhGA|≥3 (range 0-10) and was analysed at each visit. Determinants of (PGA-PhGA) were assessed at the visit level by a generalised linear mixed model.
RESULTS: A total of 702 patients were analysed at baseline (401 with complete data over 3 years): mean age 33.8±8.6 years, 379 (54.0%) female, mean symptom duration 18.1±10.5 months. Mean PGA values were always higher than mean PhGA values with a mean absolute difference of 1.8 points. At baseline, 202 (28.8%) patients had discordance mainly by PGA>PhGA; over 3 years the frequency of discordance was stable (range 25.5-28.8%). Discordance was not stable at the patient level, 118 (29.4%) patients were discordant once and 88 (22.0%) twice, and only 92 (22.9%) more than twice. Determinants of (PGA-PhGA) were spine pain (β=0.24, p<0.001) and fatigue (β=0.13, p<0.001).
CONCLUSIONS: Discordance concerned a quarter of patients with early axSpA. Over 3 years of follow-up, discordance did not decrease (no 'reference shift'). Discordance was not a stable trait, indicating discordance is not a patient characteristic. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Disease Activity; Epidemiology; Spondyloarthritis

Mesh:

Year:  2015        PMID: 26493818     DOI: 10.1136/annrheumdis-2015-208251

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

Review 1.  Incorporating the patient's perspective in outcomes research.

Authors:  Betty Hsiao; Liana Fraenkel
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

2.  Are We on the Same Page?: A Cross-Sectional Study of Patient-Clinician Goal Concordance in Rheumatoid Arthritis.

Authors:  Jennifer L Barton; Sheila Markwardt; Meike Niederhausen; Allison Schue; Jacob Dougherty; Patricia Katz; Somnath Saha; Edward H Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-09-27       Impact factor: 4.794

Review 3.  Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients.

Authors:  Marco Garrido-Cumbrera; Ottfrid Hillmann; Raj Mahapatra; David Trigos; Petra Zajc; Luisa Weiss; Galya Bostynets; Laure Gossec; Laura C Coates
Journal:  Rheumatol Ther       Date:  2017-06-09

4.  Factors associated with patient-physician discordance in a prospective cohort of patients with psoriatic arthritis: An Asian perspective.

Authors:  Charmaine Tze May Wang; Yu Heng Kwan; Warren Fong; Shu Qin Xiong; Ying Ying Leung
Journal:  Int J Rheum Dis       Date:  2019-04-03       Impact factor: 2.454

5.  Determinants of the Physician Global Assessment of Disease Activity and Influence of Contextual Factors in Early Axial Spondyloarthritis.

Authors:  Fumio Hirano; Robert B M Landewé; Floris A van Gaalen; Désirée van der Heijde; Cécile Gaujoux-Viala; Sofia Ramiro
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-13       Impact factor: 5.178

6.  Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.

Authors:  Stephanie Harvard; Daphne Guh; Nick Bansback; Pascal Richette; Alain Saraux; Bruno Fautrel; Aslam Anis
Journal:  Cost Eff Resour Alloc       Date:  2017-09-07

7.  Discordant patient-physician assessments of disease activity and its persistence adversely impact quality of life and work productivity in US Hispanics with rheumatoid arthritis.

Authors:  George A Karpouzas; Sera N Ramadan; Chelsie E Cost; Taylor L Draper; Elizabeth Hernandez; Vibeke Strand; Sarah R Ormseth
Journal:  RMD Open       Date:  2017-10-25

8.  Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort.

Authors:  Laura Pina Vegas; Emilie Sbidian; Daniel Wendling; Philippe Goupille; Salah Ferkal; Philippe Le Corvoisier; Bijan Ghaleh; Alain Luciani; Pascal Claudepierre
Journal:  Rheumatology (Oxford)       Date:  2022-04-11       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.